HYCAMTIN 1mg and 4mg solution
Product Information *
Company:
Novartis Ireland LimitedStatus:
UpdatedActive Ingredients :
*Additional information is available upon request
Legal Category:
Product subject to medical prescription which may not be renewed (A)
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 29 July 2021
File name
Hycamtin Solution_REG PIL_PF21-0181_07.06.2021_IPHA_1627557706.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 09 November 2020
File name
Hycamtin_solution_REG_SmPC_PF20-0243_IPHA_1604932351.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 November 2020
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA_1597317118.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 13 August 2020
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA_1597317118.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
Updated on 17 December 2019
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA_1576604162.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 28 March 2019
File name
Hycamtin_solution_REG_SmPC_PF18-0098_IPHA_1553790881.pdf
Reasons for updating
- File format updated to PDF
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 November 2018
File name
Hycamtin Lyvi_REG PIL_62000000029297_R91_IPHA_1541429810.pdf
Reasons for updating
- Change to section 6 - marketing authorisation number
Updated on 21 May 2018
File name
Hycamtin_solution_REG_SmPC_PF18-0098_Clean.docx
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 January 2018
File name
PIL_9170_490.pdf
Reasons for updating
- New PIL for new product
Updated on 29 January 2018
Reasons for updating
- Change to section 4 - possible side effects
- Improved presentation of PIL
Updated on 10 January 2018
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 11 October 2017
Reasons for updating
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 25 May 2016
Reasons for updating
- Change to marketing authorisation holder
Updated on 16 November 2015
Reasons for updating
- Previous version of PIL reinstated
Updated on 06 October 2014
Reasons for updating
- Addition of information on reporting a side effect.
- Change to date of revision
- Transfer of Marketing Authorisation Holder
Updated on 06 January 2014
Reasons for updating
- Change to side-effects
Updated on 30 August 2013
Reasons for updating
- Change of distributor details
Updated on 07 February 2011
Reasons for updating
- Change to side-effects
Updated on 07 April 2009
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
- Change to appearance of the medicine
- Change to side-effects
- Change to packaging
Updated on 21 August 2008
Reasons for updating
- Change to information about pregnancy or lactation
Updated on 12 June 2008
Reasons for updating
- Change to warnings or special precautions for use
Updated on 04 April 2007
Reasons for updating
- Change to side-effects
Updated on 04 August 2005
Reasons for updating
- Improved electronic presentation
Updated on 28 October 2004
Reasons for updating
- New PIL for medicines.ie